1S.S.Feng,S.Chien.Chemotherapeutic engineering:application and further development of chemical engineering principles for chemotherapy of cancer and other diseases[J].Chemical Engineering Science,2003;58:4087-5114
2L.B.Peppas,James O.Blanchette.Nanoparticle and targeted systems for cancer therapy[J].Advanced Drug Delivery Reviews,2004; 56:1649-1659
3I.Brigger,C.Dubernet,P.Couvreur.Nanoparticles in cancer therapy and diagnosis[J].Advanced Drug Delivery Reviews,2002;54:631-651
4T.Suzawa,S.Nagamura,H.Saito,et al.Enhanced tumor cell selectivity of adriamycin-monoclonal antobody conjugate via a poly (ethylene-glycol)-based cleavable linker[J].Journal of Controlled Release,2002; 79:229-242
5R.Abou-Jawde,T.Choueiri,C.Alemany,et al.An overview of targeted treatments in cancer[J].Clinical Therapeutics,2003; 25(2121-2137)
6M.Glennie,J.Winkel.Renaissance of cancer therapeutic antibodies[J].Drug Discovery Today,2002;8:503-510
7Q.-R.Chen,L.Zhang,W.Gasper,et al.Targeting tumor angiogenesis with gene therapy[J].Molecular Genetics and Metabolism,2001 ;74:120-127
8A.R.Reynolds,S.M.Moghimi,K.Hodivala-Dike.Nanoparticlemediated gene delivery to tumor vasculature[J].Trends in Molecular Medicine,2003;9:2-4
9J.D.Hood,M.Bednarski,R.Frausto,et al.Tumor regression by targeted gene delivery to the neovasculature[J].Science,2002; 296:2404-2407
10F.Si-Shen,H.Guofeng.Effect of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymer[J].Journal of Controlled Release,2001 ;71:53-69